Showing results (221-230 of 277) with videos related to

Sort By:
Pageof 28
Oncotarget|August 29, 2015
Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven originLijuan Deng, Yuqin Song, Ken H Young, et al.
Investigational New Drugs|July 7, 2023
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphomaYuqin Song, Keshu Zhou, Shenmiao Yang, et al.
Leukemia & Lymphoma|March 17, 2026
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinionWon Seog Kim, Mubarak Al Mansour, Chan Cheah, et al.
Eclinicalmedicine|August 18, 2025
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I studyZhengfu Fan, Jin Wang, Dan Liu, et al.
Nature Communications|May 16, 2025
Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trialYuqin Song, Jun Ma, Huilai Zhang, et al.
BMC Cancer|February 26, 2021
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignanciesZhitao Ying, Ting He, Xiaopei Wang, et al.
Blood|March 18, 2022
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 studyYuqin Song, Keshu Zhou, Dehui Zou, et al.
Annals of Hematology|July 7, 2022
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphomaFei Qi, Yan Xie, Dedao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker AnalysisYuqin Song, Quanli Gao, Huilai Zhang, et al.
The Journal of Antimicrobial Chemotherapy|November 9, 2023
Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animalsJuan Li, Yuqin Song, Jianping Deng, et al.
Pageof 28